Literature DB >> 24370660

Comparison of in vitro antiviral activity of tea polyphenols against influenza A and B viruses and structure-activity relationship analysis.

Zi-Feng Yang1, Li-Ping Bai2, Wen-bo Huang3, Xu-Zhao Li3, Sui-Shan Zhao3, Nan-Shan Zhong4, Zhi-Hong Jiang5.   

Abstract

Influenza poses a particular risk of severe outcomes in the elderly, the very young and those with underlying diseases. Tea polyphenols are the natural phenolic compounds in teas, and principally consist of catechins, proanthocyanidins, flavonols, and theaflavins, which antiviral activities have been reported recently. This study is to gain a further insight into potential of various tea polyphenols for inhibiting influenza virus infection. Five tea polyphenols exhibited inhibitory activity against influenza A virus in the trend of theaflavin>procyanidin B-2>procyanidin B-2 digallate>(-)-epigallocatechin(EGC)>(-)-epigallocatechingallate(EGCG) with IC50 values in the range of 16.2-56.5 μg/ml. Six of the tested compounds showed anti-influenza B virus activity in the order of kaempferol>EGCG>procyanidin B-2>(-)-EGC~methylated EGC>theaflavin with IC50 values in the range of 9.0-49.7 μg/ml. Based on these results, the structure-activity relationship (SAR) was explained as follows. First, the dimeric molecules, such as theaflavin and procyanidin B-2, generally displayed more potent antiviral activity against both influenza A and B viruses than the catechin monomers. Second, the kaempferol for inhibition of influenza B virus indicated that the more planar flavonol structure with only one C-4' phenolic hydroxyl group in the B ring is necessary for the anti-influenza B virus activity. A similar SAR can be drawn from the assays of another enveloped RNA virus, such as respiratory syncytial virus. These results are expected to provide guides for rational design of antiviral drugs based on polyphenols.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  (−)-Epicatechin (PubChem CID: 72276); (−)-Epicatechingallate (PubChem CID: 107905); (−)-Epigallocatechin (PubChem CID: 72277); (−)-Epigallocatechingallate (PubChem CID: 65064); Antiviral; Influenza virus; Kaempferol (PubChem CID: 5280863); Myricetin (PubChem CID: 5281672); Procyanidin B2 (PubChem CID: 122738); Quercetin (PubChem CID: 5280343); Structure–activity relationship; Tea polyphenols; Theaflavin(PubChem CID: 114777); Theaflavindigallate (PubChem CID: 44448535)

Mesh:

Substances:

Year:  2013        PMID: 24370660     DOI: 10.1016/j.fitote.2013.12.011

Source DB:  PubMed          Journal:  Fitoterapia        ISSN: 0367-326X            Impact factor:   2.882


  43 in total

Review 1.  Induction of cellular and molecular immunomodulatory pathways by vitamin A and flavonoids.

Authors:  Sapna Patel; Michael Vajdy
Journal:  Expert Opin Biol Ther       Date:  2015-07-17       Impact factor: 4.388

2.  Anti-Influenza Virus Activity of Adlay Tea Components.

Authors:  Emiko Nagai; Miwa Iwai; Ritsuko Koketsu; Yoshinobu Okuno; Yuri Suzuki; Ryosuke Morimoto; Hidenobu Sumitani; Atsushi Ohshima; Toshiki Enomoto; Yuji Isegawa
Journal:  Plant Foods Hum Nutr       Date:  2019-12       Impact factor: 3.921

3.  Epigallocatechin gallate inhibits hepatitis B virus via farnesoid X receptor alpha.

Authors:  Jun Xu; Weizhen Gu; Chaoyan Li; Xiao Li; Guozhen Xing; Yan Li; Yanhui Song; Wenming Zheng
Journal:  J Nat Med       Date:  2016-03-11       Impact factor: 2.343

4.  Anti-HCV Tannins From Plants Traditionally Used in West Africa and Extracted With Green Solvents.

Authors:  Moussa Bamba; Simon Bordage; Marie-Emmanuelle Sahuc; Sophie Moureu; Jennifer Samaillie; Vincent Roumy; Peggy Vauchel; Krasimir Dimitrov; Yves Rouillé; Jean Dubuisson; Fézan Honora Tra Bi; Karin Séron; Sevser Sahpaz
Journal:  Front Pharmacol       Date:  2022-01-28       Impact factor: 5.810

5.  Investigation of the Azorean Camellia sinensis Processing Conditions to Maximize the Theaflavin 3,3'-di-O-Gallate Content as a Potential Antiviral Compound.

Authors:  Lisete Paiva; Elisabete Lima; Madalena Motta; Massimo Marcone; José Baptista
Journal:  Antioxidants (Basel)       Date:  2022-05-27

6.  Prevention of hepatitis C virus infection using a broad cross-neutralizing monoclonal antibody (AR4A) and epigallocatechin gallate.

Authors:  Daire O'Shea; John Law; Adrian Egli; Donna Douglas; Gary Lund; Sarah Forester; Joshua Lambert; Mansun Law; Dennis R Burton; D L J Tyrrell; Michael Houghton; Atul Humar; Norman Kneteman
Journal:  Liver Transpl       Date:  2016-01-29       Impact factor: 5.799

7.  Antiviral effect of theaflavins against caliciviruses.

Authors:  Mai Ohba; Tomoichiro Oka; Takayuki Ando; Saori Arahata; Asaka Ikegaya; Hirotaka Takagi; Naohisa Ogo; Chelsea Zhu; Kazuhiro Owada; Fumihiko Kawamori; Qiuhong Wang; Linda J Saif; Akira Asai
Journal:  J Antibiot (Tokyo)       Date:  2016-10-19       Impact factor: 2.649

8.  Previously published ethno-pharmacological reports reveal the potentiality of plants and plant-derived products used as traditional home remedies by Bangladeshi COVID-19 patients to combat SARS-CoV-2.

Authors:  A T M Rafiqul Islam; Jannatul Ferdousi; Md Shahinozzaman
Journal:  Saudi J Biol Sci       Date:  2021-07-17       Impact factor: 4.219

9.  Investigation of the salicylaldehyde thiosemicarbazone scaffold for inhibition of influenza virus PA endonuclease.

Authors:  Dominga Rogolino; Alessia Bacchi; Laura De Luca; Gabriele Rispoli; Mario Sechi; Annelies Stevaert; Lieve Naesens; Mauro Carcelli
Journal:  J Biol Inorg Chem       Date:  2015-09-01       Impact factor: 3.862

Review 10.  Targeting TLR4 Signaling to Blunt Viral-Mediated Acute Lung Injury.

Authors:  Kari Ann Shirey; Jorge C G Blanco; Stefanie N Vogel
Journal:  Front Immunol       Date:  2021-07-02       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.